Santen Pharmaceutical Co (JP:4536) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Santen Pharmaceutical Co., Ltd. has successfully completed the disposal of 93,391 treasury shares at 1,623.5 yen per share on July 22, 2024, following a resolution by its Board of Directors. A total of 151,620,288.5 yen was raised through this disposal, which was allotted among 4 Directors and 10 Corporate Officers. This move is part of the company’s Restricted Stock-Linked Remuneration Program aimed at incentivizing its leadership team.
For further insights into JP:4536 stock, check out TipRanks’ Stock Analysis page.